| 8.15 Data as of May 17 |  -0.10 / -1.21%Today’s Change | 7.25 Today|||52-Week Range 17.92 | -38.77% Year-to-Date |
| Previous close | 8.25 |
| Today’s open | 8.15 |
| Day’s range | 8.15 - 8.15 |
| Volume | 571 |
| Average volume (3 months) | 5,218 |
| Market cap | $231.2M |
| Dividend yield | -- |
| Earnings growth (last year) | -29.80% |
| Earnings growth (this year) | +40.97% |
| Earnings growth (next 5 years) | -43.10% |
| Revenue growth (last year) | -18.38% |
| P/E ratio | -- |
| Price/Sales | 410.56 |
| Price/Book | 4.59 |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $915.5K |
| Annual profit (last year) | -$14.2M |
| Net profit margin | -1,550.28% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Executive Director Jackie K. Fairley, PhD, MBA |
Chief Financial Officer Nigel J. Baade, CPA |
Corporate headquarters Melbourne, Victoria (vic) |
.
